Clinical Trial Update: Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for a subset of HPV-015 study subjects focusing on gynecologic follow-up; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillomavirus Infections

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 3 | Status: COMPLETED | Results posted: 2018-10-17